Isao Miyazaki

977 total citations
35 papers, 651 citations indexed

About

Isao Miyazaki is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Isao Miyazaki has authored 35 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Genetics and 10 papers in Oncology. Recurrent topics in Isao Miyazaki's work include Genetic and Kidney Cyst Diseases (8 papers), Renal and related cancers (6 papers) and Viral-associated cancers and disorders (5 papers). Isao Miyazaki is often cited by papers focused on Genetic and Kidney Cyst Diseases (8 papers), Renal and related cancers (6 papers) and Viral-associated cancers and disorders (5 papers). Isao Miyazaki collaborates with scholars based in Japan, Canada and United States. Isao Miyazaki's co-authors include Roy K. Cheung, Hans‐Michael Dosch, Hiroyuki Osada, Siro Simizu, Raphael Feinmesser, Hideo Okumura, Arnold M. Noyek, Jeremy L. Freeman, Satoshi Takagi and Eiji Higashihara and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Isao Miyazaki

33 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isao Miyazaki Japan 12 251 215 172 99 99 35 651
Ravindran Ankathil Malaysia 22 318 1.3× 649 3.0× 267 1.6× 131 1.3× 92 0.9× 99 1.3k
Alexandros Spyridonidis Greece 20 272 1.1× 281 1.3× 83 0.5× 51 0.5× 234 2.4× 75 1.1k
Sei Kyung Chang South Korea 12 252 1.0× 163 0.8× 62 0.4× 143 1.4× 259 2.6× 28 692
Ivan Ngai United States 13 266 1.1× 496 2.3× 105 0.6× 41 0.4× 48 0.5× 22 819
Hiroaki Ohnishi Japan 16 274 1.1× 291 1.4× 45 0.3× 68 0.7× 73 0.7× 52 774
W E Grizzle United States 11 173 0.7× 352 1.6× 258 1.5× 97 1.0× 32 0.3× 19 681
Debora Martorelli Italy 20 564 2.2× 186 0.9× 48 0.3× 149 1.5× 369 3.7× 34 989
Katsumi Tsukazaki Japan 18 245 1.0× 452 2.1× 85 0.5× 56 0.6× 174 1.8× 65 1.1k
Florentia Fostira Greece 14 245 1.0× 434 2.0× 416 2.4× 179 1.8× 19 0.2× 56 942
C Wiltschke Austria 14 346 1.4× 232 1.1× 179 1.0× 31 0.3× 174 1.8× 29 703

Countries citing papers authored by Isao Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Isao Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Miyazaki more than expected).

Fields of papers citing papers by Isao Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Miyazaki. The network helps show where Isao Miyazaki may publish in the future.

Co-authorship network of co-authors of Isao Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Miyazaki. A scholar is included among the top collaborators of Isao Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Miyazaki. Isao Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Isao, et al.. (2024). Preclinical evaluation of targeted therapies for central nervous system metastases. Disease Models & Mechanisms. 17(9). 3 indexed citations
2.
3.
Odintsov, Igor, Kota Ishizawa, Isao Miyazaki, et al.. (2022). Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.. Journal of Clinical Oncology. 40(16_suppl). 2024–2024. 8 indexed citations
4.
Higashihara, Eiji, Hiroshi Fukuhara, John Ouyang, et al.. (2020). Estimation of Changes in Kidney Volume Growth Rate in ADPKD. Kidney International Reports. 5(9). 1459–1471. 8 indexed citations
5.
Kato, Fumihiro, Yasunori Nio, Riéko Suzuki, et al.. (2019). Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase. Antiviral Research. 172. 104643–104643. 11 indexed citations
6.
Yoshida, Hiroki, Eiji Higashihara, Keisuke Maruyama, et al.. (2017). Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease. Acta Neurochirurgica. 159(12). 2325–2330. 11 indexed citations
7.
Higashihara, Eiji, Shigeo Horie, Moritoshi Kinoshita, et al.. (2017). A potentially crucial role of the PKD1 C-terminal tail in renal prognosis. Clinical and Experimental Nephrology. 22(2). 395–404. 7 indexed citations
8.
9.
Higashihara, Eiji, et al.. (2014). Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?. Nephrology Dialysis Transplantation. 29(9). 1710–1719. 42 indexed citations
10.
Higashihara, Eiji, Kikuo Nutahara, Takatsugu Okegawa, et al.. (2014). Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan. Clinical and Experimental Nephrology. 19(4). 746–752. 5 indexed citations
11.
Miyazaki, Isao, Siro Simizu, & Hiroyuki Osada. (2010). The Application of the Chemical Array for Biological Study. Methods in molecular biology. 669. 95–107. 3 indexed citations
12.
Miyazaki, Isao, Siro Simizu, Keisuke Ishida, & Hiroyuki Osada. (2009). On‐Chip Fragment‐Based Approach for Discovery of High‐Affinity Bivalent Inhibitors. ChemBioChem. 10(5). 838–843. 8 indexed citations
13.
Miyazaki, Isao, Hideo Okumura, Siro Simizu, et al.. (2009). Structure–Affinity Relationship Study of Bleomycins and Shble Protein by Use of a Chemical Array. ChemBioChem. 10(5). 845–852. 12 indexed citations
14.
Miyazaki, Isao, Siro Simizu, Harumi Ichimiya, Makoto Kawatani, & Hiroyuki Osada. (2008). Robust and Systematic Drug Screening Method Using Chemical Arrays and the Protein Library: Identification of Novel Inhibitors of Carbonic Anhydrase II. Bioscience Biotechnology and Biochemistry. 72(10). 2739–2749. 29 indexed citations
15.
16.
Miyazaki, Isao, et al.. (1994). Cloning of humna and rat p69 cDNA, a candidate autoimmune target in type 1 diabetes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1227(1-2). 101–104. 26 indexed citations
17.
Cheung, Roy K., et al.. (1994). EPSTEIN-BARR VIRUS SURVEILLANCE AFTER RENAL TRANSPLANTATION. Transplantation. 57(8). 1182–1189. 28 indexed citations
18.
Miyazaki, Isao, Roy K. Cheung, & Hans‐Michael Dosch. (1994). The role of vIL-10 and other EBV latency genes early during B cell growth transformation. Seminars in Virology. 5(6). 405–414. 6 indexed citations
19.
Miyazaki, Isao, Roy K. Cheung, & Hans‐Michael Dosch. (1993). Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.. The Journal of Experimental Medicine. 178(2). 439–447. 116 indexed citations
20.
Noguchi, Masakuni, et al.. (1989). [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].. PubMed. 90(5). 780–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravindran Ankathil Breakdown of academic impact, for papers by Alexandros Spyridonidis Breakdown of academic impact, for papers by Sei Kyung Chang Breakdown of academic impact, for papers by Ivan Ngai Breakdown of academic impact, for papers by Hiroaki Ohnishi Breakdown of academic impact, for papers by W E Grizzle Breakdown of academic impact, for papers by Debora Martorelli Breakdown of academic impact, for papers by Katsumi Tsukazaki Breakdown of academic impact, for papers by Florentia Fostira Breakdown of academic impact, for papers by C Wiltschke
Rankless by CCL
2026